-

Protests: AHF Blasts Gilead Over Extortionate AIDS Drug Pricing

Daily April 14-17, Gilead HQ, 10:30 a.m. -11:30 a.m.

HIV drug maker’s pricing for its lifesaving HIV drugs puts nation’s HIV safety nets under tremendous strain; one Gilead’s HIV medication, Biktarvy, carried an annual sticker price of nearly $61,000 per patient in 2025

SAN FRANCISCO--(BUSINESS WIRE)--Advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF) will host a weeklong series of protests targeting HIV drug giant, Gilead Sciences, at its Foster City, CA, headquarters. The group is targeting the Bay Area drug company over its extortionate pricing for its lifesaving HIV medications.

Gilead’s steep HIV drug pricing was a contributing factor in Florida’s recent move to restrict access to its AIDS Drug Assistance Program (ADAP), which put Florida’s HIV safety net at risk. Nearly 20 other states have similarly scaled back their ADAPs.

Share

WHAT:

Drug pricing protests at Gilead’s ‘Greediad’ Foster City HQ

 

 

WHEN:

Tuesday, April 14

 

10:30 a.m. – 11:30 a.m.

 

Wednesday, April 15

 

10:30 a.m. – 11:30 a.m.

 

Thursday April 16

 

10:30 a.m. – 11:30 a.m.

 

Friday, April 17

 

10:30 a.m. – 11:30 a.m.

 

 

 

 

WHERE:

Across from:

 

Gilead Sciences, Inc. Headquarters

 

400 block of Mariners Island Blvd, Foster City, CA 94404

 

 

 

 

WHO:

15+ advocates & mobilizers protesting daily with signs reading “Stop Being Greedy” and other handwritten signs

Gilead’s pricing was a contributing factor in the State of Florida’s recent move to drastically restrict access to its AIDS Drug Assistance Program (ADAP), which put Florida’s HIV safety net under tremendous strain. This past weekend, AHF ran full page ads in five major Florida daily newspapers sharply criticizing Gilead over its drug pricing and policies. AHF’s “Greediad” ads were addressed to “Greedy Gilead.”

Florida is not alone dealing with high HIV drug prices. According to U.S. News and World Report, nearly 20 states have scaled back their HIV medication programs, and five more are considering similar restrictions. High drug prices, such as $61,000 annually per patient for Gilead’s HIV treatment, Biktarvy, are a significant factor. Other factors include the fact that “(ADAP) Enrollment increased by 30% from 2022 to 2024, in part because states began removing people from Medicaid after the pandemic. At the same time, federal funding has remained flat for more than a decade, even as drug prices and insurance premiums have increased.”

AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 2.9 million individuals across 50 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. In January 2025, AHF received the MLK, Jr. Social Justice Award, The King Center’s highest recognition for an organization leading work in the social justice arena. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, and follow us on Instagram, Twitter, and TikTok.

Contacts

Media Contact:
Jesse Brooks, AHF Mobilizer, Bay Area
Cell: 510-575-8245 jesse.brooks@ahf.org

AIDS Healthcare Foundation


Release Summary
Protests: AHF Blasts Gilead Over Extortionate AIDS Drug Pricing
Release Versions
Hashtags

Contacts

Media Contact:
Jesse Brooks, AHF Mobilizer, Bay Area
Cell: 510-575-8245 jesse.brooks@ahf.org

Social Media Profiles
More News From AIDS Healthcare Foundation

AHF Welcomes Lula–Tedros Call for Equity in Pandemic Agreement, Warns against Rushing Empty Deal

MIAMI, GENEVA & SÃO PAULO--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) and the AHF Global Public Health Institute welcome the open letter issued by President Luiz Inácio Lula da Silva of Brazil and World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus on the occasion of the G7 Summit, calling on the leaders of the G7, G20, BRICS, and all nations to finish the Pathogen Access and Benefit-Sharing (PABS) annex of the WHO Pandemic Agreement. AHF particularly commends t...

AHF: Ebola Outbreak Exposes Need for Stronger Investment in Preparedness

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) calls for stronger investments in Ebola preparedness and response as the current outbreak in the Democratic Republic of the Congo and Uganda underscores the continued threat posed by the deadly disease and the urgent need to strengthen public health systems across Africa. The outbreak is caused by the Bundibugyo virus strain, for which there is currently no approved vaccine or specific treatment. While progress has been made in...

End the Global Debt Trap: Freedom from Debt Now, says AHF

LOS ANGELES--(BUSINESS WIRE)--As part of the global Freedom from Debt campaign launch, nearly 50 AIDS Healthcare Foundation (AHF) country teams and partners will commence multiple in-person and virtual advocacy actions that call for urgent reforms to a global debt system that prevents developing countries from investing in healthcare, education, and other basic human needs. Debt injustice demands a global system that prioritizes people over profit and ensures countries can meet the basic needs...
Back to Newsroom